Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Francesco Malandrini"'
Autor:
Anna Amela Valsecchi, Filippo Giovanardi, Francesco Malandrini, Michela Meregaglia, Alberto Servetto, Chiara Bennati, Carmine Pinto, Massimo Di Maio, Oriana Ciani
Publikováno v:
Breast, Vol 78, Iss , Pp 103817- (2024)
Background: Inclusion of patient-reported outcomes (PROs) in oncology clinical trials is strongly recommended. However, selecting the most appropriate patient-reported outcome measures (PROMs) is not easy. This study aimed to develop a breast cancer
Externí odkaz:
https://doaj.org/article/37033068ba08440294db2b5dd2fcb9b0
Autor:
Alice Tarantola, Monica Hildegard Otto, Patrizio Armeni, Francesco Costa, Francesco Malandrini, Claudio Jommi
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 16, Iss 1, Pp 1-13 (2023)
Abstract Early access programs (EAPs) generally refer to patient access to medicines/indications before marketing authorization, possibly extended to price and reimbursement approval. These programs include compassionate use, which is usually covered
Externí odkaz:
https://doaj.org/article/8d6401fd725a4f5fb756bbf97b1bb5c0
Publikováno v:
Global & Regional Health Technology Assessment, Vol 10, Iss 1 (2023)
The attention paid by regulatory authorities to patient-reported outcomes (PROs) and their related measures (PROMs) has progressively increased to allow for a more complete description of the patient’s health status. This work aimed at investigatin
Externí odkaz:
https://doaj.org/article/10c2d882eb7040c39bd228e59c95ce66
This study aimed to provide normative data obtained in response to the EQ-5D-5L questionnaire in Italy and compare this with data from other countries.A sample of the Italian adult population (aged ≥ 18 years) was recruited and interviewed online u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234d43a0c7795be6832117c155ae6f7f
https://hdl.handle.net/11565/4051606
https://hdl.handle.net/11565/4051606
